SCHEMBL7018735

SCHEMBL7018735

C[C@H](Nc1nccc(-n2cnc3cc(NC(=O)[C@@H]4CCCN4C(=O)OCc4ccccc4)ccc32)n1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LCK P06239 14/20 0.57
KDM4E B2RXH2 1/20 0.51
LMNA P02545 1/20 0.51
HSD17B10 Q99714 1/20 0.50
ALDH1A1 P00352 1/20 0.49
TSHR P16473 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
KDM1A O60341 1/20 0.46
RCOR1 Q9UKL0 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7016606 0.89 POLB (0.54) LCK
SCHEMBL7018108 0.89 LCK (0.53) LCK
SCHEMBL7013212 0.88 LCK (0.57) LCK
SCHEMBL7590193 0.88 LCK (0.57) LCK
SCHEMBL7022809 0.87 LCK (0.52) LCK
SCHEMBL7019412 0.87 LCK (0.52) LCK
SCHEMBL7018133 0.86 LCK (0.55) LCK
SCHEMBL7102009 0.86 LCK (0.55) LCK
SCHEMBL7024810 0.86 LCK (0.59) LCK
SCHEMBL7589810 0.85 LCK (0.58) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed